Streetbeat News

Stock Prices

VRTX

Vertex Pharmaceuticals presented new data at the ECFS 47th European Cystic Fibrosis Conference showing significant benefits of TRIKAFTA in treating cystic fibrosis with rare, non-F508del CFTR mutations. The study demonstrated improvements in lung function, CFTR function, and reduced pulmonary exacerbations.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2024 | 4:03 pm

ASXC

KARL STORZ Endoscopy-America, Inc. has agreed to acquire Asensus Surgical Inc. (NYSE:ASXC) for $0.35 per share in cash, representing a significant premium. The transaction is expected to close in Q3 2024, after which Asensus will no longer be publicly traded.

Portfolio Pulse from Vandana Singh

June 07, 2024 | 4:02 pm

HY

Hyster Yale (NYSE:HY) has received mixed analyst ratings over the past three months, with a recent increase in the average 12-month price target to $88.5. Analysts have maintained or raised their ratings, reflecting positive sentiment. The company has shown strong financial performance with notable revenue growth, net margin, ROE, and ROA, but carries a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

June 07, 2024 | 4:01 pm

BKKT

Bakkt Holdings shares are trading higher following a report suggesting the company is considering a potential sale or breakup.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2024 | 4:01 pm

FCFS

FirstCash Holdings (NASDAQ:FCFS) has outperformed the market over the past 15 years with an average annual return of 13.88%, resulting in a $100 investment growing to $698.52. The company currently has a market capitalization of $5.22 billion.

Portfolio Pulse from Benzinga Insights

June 07, 2024 | 4:00 pm

MARA

Marathon Digital Holdings (NASDAQ:MARA) has significantly outperformed the market over the past 5 years, with an annualized return of 58.27%. A $1000 investment in MARA 5 years ago would be worth $9,694.55 today.

Portfolio Pulse from Benzinga Insights

June 07, 2024 | 4:00 pm

SPB

Six analysts have recently evaluated Spectrum Brands Holdings (NYSE:SPB), with a mix of bullish and indifferent ratings. The average 12-month price target has increased to $103.5, reflecting an 11.29% rise from the previous target. Analysts have raised their price targets, indicating a positive outlook despite the company's financial challenges.

Portfolio Pulse from Benzinga Insights

June 07, 2024 | 4:00 pm

BKKT

Crypto marketplace Bakkt is considering a potential sale or breakup, according to Bloomberg. This strategic review comes as the company evaluates its future direction amidst a challenging market environment.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2024 | 3:59 pm

AFRM

FINX

IPAY

Affirm Holdings, Inc (NASDAQ:AFRM) has introduced new payment options, Pay in 2 and Pay in 30, to enhance flexibility and affordability for consumers. These options allow users to split purchases into two interest-free payments or pay in full within 30 days without late fees. The rollout has already increased cart conversion, and Affirm plans to extend these options to merchant partners. Affirm also expanded its partnership with Alterra Mountain Company. AFRM shares were trading lower by 2.69% at $30.32. Investors can gain exposure via Amplify Mobile Payments ETF (NYSE:IPAY) and Global X FinTech ETF (NASDAQ:FINX).

Portfolio Pulse from Anusuya Lahiri

June 07, 2024 | 3:56 pm

ULCC

Frontier Group's shares spiked higher following rumors that the company would pause sales at 12ET to watch Roaring Kitty.

Portfolio Pulse from Benzinga Newsdesk

June 07, 2024 | 3:56 pm